✦ LIBER ✦

A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy

✍ Scribed by Giorgio Saracco; Giuseppe Mazzella; Floriano Rosina; Claudio Cancellieri; Valter Lattore; Enzo Raise; Giuseppe Rocca; Laura Giorda; Giorgio Verme; Giovanni Gasbarrini; Luigi Barbara; Ferruccio Bonino; Dr. Mario Rizzetto; Enrico Roda

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 643 KB
Volume: 10
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840100315

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphoblastoid interferon in controlled

Lymphoblastoid interferon in controlled trials of chronic hepatitis B virus infection

✍ Stephanos J. Hadziyannis 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

A randomized controlled trial of lymphob

A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B lacking HBeAg

✍ Giovanna Fattovich; Patrizia Farci; Massimo Rugge; Lucio Brollo; Antonella Manda 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Ongoing hepatitis B virus replication in the presence of antibody to HBeAg can be observed in patients with active liver disease. These forms of chronic hepatitis B have been described as having a poor prognosis. We have conducted a randomized controlled trial to assess the efficacy of lymphoblastoi

Lymphoblastoid interferon alfa with or w

Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: A multicenter controlled trial

✍ G V Gregorio; P Jara; L Hierro; C Diaz; A de la Vega; A Vegnente; R Iorio; F Bor 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

## Steroid priming does not potentiate the effect of IFN-a. The comparative efficacy of prednisolone followed by (HEPATOLOGY 1996;23:700-707.) interferon alfa (IFN-a) versus IFN-a alone in enhancing the rate of antibody to hepatitis B e antigen (anti-HBe) seroconversion has not been evaluated in a

Prospective, randomized controlled trial

Prospective, randomized controlled trial of interferon-α in children with chronic hepatitis B

✍ Mercedes Ruiz-Moreno; Maria José Rua; Josefina Molina; Gloria Moraleda; Alberto 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 522 KB

Thirty-six children with chronic hepatitis B were entered into a randomized controlled trial of recombinant human interferon-a. All patients had hepatitis B virus DNA and increased levels of aminotransferases in serum for at least 1 yr. Twelve children received 10 MU of interferon-a 2b/m2 body surfa

Recombinant human α-interferon in patien

Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France

✍ Patrick Marcellin; Nathalie Boyer; Emile Giostra; Claude Degott; Anne Marie Cour 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

We have conducted a multicenter randomized controlled trial comparing two doses of recombinant human a-interferon for efficacy in 60 patients with chronic non-A, non-B hepatitis. The source of infection appeared to be transfusion in 30 patients, intravenous drug abuse in 16 patients and was unknown

A randomised controlled trial of recombi

A randomised controlled trial of recombinant interferon-γ in chinese patients with chronic hepatitis B virus infection

✍ Johnson Y. N. Lau; Dr. C. L. Lai; P. C. Wu; H. T. Chung; Anna S. F. Lok; H. J. L 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

## Abstract Nineteen Chinese patients with chronic hepatitis B virus (HBV) infection, seropositive for HBV e antigen (HBeAg) and HBV DNA on at least three occasions in 6 months, were randomised to receive either recombinant human interferongamma (rlFNγ) 0.1 mg/m^2^ intramuscularly thrice weekly for